NEWARK, DE / ACCESSWIRE / July 7, 2016 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today that it filed a new patent app